Clinical trial Recruiting at 1 site Observational Ages 18 to 90

Identifying sex-specific biological markers in valvular heart disease

Official title: Novel Characterization of Sex Specific Biologic Signatures in Valvular Heart Disease

Run by The Cleveland Clinic · NCT06780241 · Data updated 2026-11-12

This study is testing if special heart scans can help find different biological markers for men and women with aortic valve disease to improve treatment and recovery after surgery.

More Aortic Stenosis trials

Quick facts

Study typeObservational
Ages18 Years to 90 Years
SexAll
Enrollment200 (estimated)
SponsorThe Cleveland Clinic
Academic / other
Locations1 site (Cleveland, Ohio)
StatusRecruiting
StartedDecember 10, 2024
Main results expectedDecember 31, 2030
Study endsDecember 31, 2030
Registry record updatedJanuary 2, 2026
Trial IDNCT06780241 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-90 with suspected moderate to severe aortic regurgitation or aortic stenosis.

Probably not a fit

Patients with acute traumatic cardiac injury, congenital heart diseases, or contraindications to cardiac MRI may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to validate sex-specific biological signatures associated with aortic valve disease using advanced cardiac magnetic resonance (CMR) techniques. By employing methods such as Magnetic Resonance Fingerprinting (MRF), Diffusion Tensor Imaging (DTI), and radiomics analysis, the study seeks to identify predictors of reverse remodeling following aortic valve surgery. The goal is to develop sex-specific thresholds for risk and treatment response, addressing the current lack of consideration for sex differences in existing guidelines for valvular heart disease. The infrastructure created will support a precision medicine approach in cardiovascular imaging.

Why it matters

Potential benefit: If successful, this study could lead to more personalized and effective treatment strategies for patients with valvular heart disease based on their sex.

How similar studies have gone: Other studies have shown success in identifying sex differences in cardiovascular outcomes, suggesting that this approach may yield valuable insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18-90 years of age
* Suspected moderate or severe (2-3+ or more) aortic regurgitation, or moderate or more aortic stenosis on the basis of prior known clinical history, echocardiogram or cardiac MRI.

Exclusion Criteria:

* Acute traumatic cardiac injury
* Aortic dissection or aortic root rupture
* Congenital heart diseases such as patent ductus arteriosus, coarctation of aorta, ASD and VSD
* Presence of A-V fistula or intracardiac shunts
* Any contraindications to cardiac MRI including:

  * Patients with any MR-incompatible implant, including cardiac pacemakers or defibrillators, or older types of cerebral aneurysm clips.
  * Patients who weigh more than 440 lbs. or have a very wide waist circumference.
  * Patients with claustrophobia may have difficulty tolerating the exam.

Where it's running

  • Cleveland Clinic
    Cleveland, Ohio, United States
    Recruiting

Study contacts

  • Principal investigator: Deborah Kwon, MD — The Cleveland Clinic
  • Study coordinator: Deborah Kwon, MD
  • Email: kwond@ccf.org
  • Phone: 216-444-8526

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.